HNB
CPRX

Hilltop National Bank’s Catalyst Pharmaceutical CPRX Stock Holding History

Hilltop National Bank’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.3K Hold
900
– – 0.01% 564
2026
Q1 		$22.3K Hold
900
– – 0.01% 572
2025
Q4 		$21K Hold
900
– – 0.01% 577
2025
Q3 		$17.7K Hold
900
– – ﹤0.01% 586
2025
Q2 		$19.5K Buy
+900
New +$21.2K 0.01% 568
2024
Q4 		$18.8K Hold
900
– – 0.01% 565
2024
Q3 		$17.9K Hold
900
– – 0.01% 600
2024
Q2 		$13.9K Hold
900
– – ﹤0.01% 611
2024
Q1 		$14.3K Buy
+900
New +$13.6K ﹤0.01% 592

Other funds holding CPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Hilltop National Bank's CPRX Position: Q2 2026 in Review

Hilltop National Bank held its Catalyst Pharmaceutical (CPRX) position steady in Q2 2026 at 900 shares worth $28.3K. The position accounts for 0.01% of the portfolio, ranked #564.

Hilltop National Bank first reported a position in CPRX in Q1 2024 and has held it in 9 quarters since. 36 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Hilltop National Bank held 900 shares of Catalyst Pharmaceutical worth $28.3K as of Q2 2026.
  • Hilltop National Bank left its Catalyst Pharmaceutical share count unchanged in Q2 2026.
  • Catalyst Pharmaceutical made up 0.01% of Hilltop National Bank's portfolio in Q2 2026, its #564 holding.
  • Hilltop National Bank first reported a position in Catalyst Pharmaceutical in Q1 2024 and has held it in 9 quarters since.
  • 36 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.